Towa Pharmaceutical Co., Ltd. (TWAPF) - Analysis

opens in 1d 21h 17m

005930 186,200.00 4.37%
0700 488.60 -1.61%
2330 1,810.00 -2.43%
ASML 1,161.00 -2.24%
AZN 15,316.00 1.96%
ETH/USD 2,054.76 0.05%
EUR/USD 1.15 0.03%
MC 471.05 -0.01%
NESN 78.66 0.34%
USD/JPY 159.60 -0.02%
XPT/USD 1,003.20 0.33%

005930 186,200.00 4.37%
0700 488.60 -1.61%
2330 1,810.00 -2.43%
ASML 1,161.00 -2.24%
AZN 15,316.00 1.96%
ETH/USD 2,054.76 0.05%
EUR/USD 1.15 0.03%
MC 471.05 -0.01%
NESN 78.66 0.34%
USD/JPY 159.60 -0.02%
XPT/USD 1,003.20 0.33%

005930 186,200.00 4.37%
0700 488.60 -1.61%
2330 1,810.00 -2.43%
ASML 1,161.00 -2.24%
AZN 15,316.00 1.96%
ETH/USD 2,054.76 0.05%
EUR/USD 1.15 0.03%
MC 471.05 -0.01%
NESN 78.66 0.34%
USD/JPY 159.60 -0.02%
XPT/USD 1,003.20 0.33%

005930 186,200.00 4.37%
0700 488.60 -1.61%
2330 1,810.00 -2.43%
ASML 1,161.00 -2.24%
AZN 15,316.00 1.96%
ETH/USD 2,054.76 0.05%
EUR/USD 1.15 0.03%
MC 471.05 -0.01%
NESN 78.66 0.34%
USD/JPY 159.60 -0.02%
XPT/USD 1,003.20 0.33%

16.83000 USD

0

0%

Last update Apr 4, 10:53 AM EDT

Market closed

Day range

16.83000

16.83000

25.33000

Previous close

16.83000

Open

25.33000

Access this stock data via API

Towa Pharmaceutical Co., Ltd.

16.83

0

0%

Analysis

Revenue estimate	Next year (Mar 2027)
Number of Analysts	5
Avg. estimate	296.50B
Low estimate	288.71B
High estimate	302B
Last year sales	277.85B
Sales growth	0.07

Access /revenue_estimate data via our API — starting from the Ultra plan (individual) and the Enterprise plan (business) and above.

EPS revisions	Next year (Mar 2027)
Up last 7 days	0
Up last 30 days	0
Down last 7 days	0
Down last 30 days	0

Access /eps_revisions data via our API — starting from the Ultra plan (individual) and the Enterprise plan (business) and above.